Oxygenta Pharmaceutical Ltd - Board Meeting Outcome for Submission Of Audited Financial Results For The Quarter And Year Ended 31St March, 2023
Download 
|
< Back |
| 30 May 2023 | |
| The Board at its meeting held today, i.e., Tuesday, 30th May, 2023, transacted inter-alia, the following businesses: 1. Financial Results: The Board approved the Audited Financial Results for the quarter and year ended 31st March, 2023. In this regard please find the enclosed: ? Audited Financial Results of the Company for the quarter and year ended 31st March, 2023 ? Auditor's report in respect of the Audited Financial Results of the Company for the quarter and year ended 31st March, 2023 ? Declaration pursuant to Regulation 33(3)(d) of Listing Regulations in terms of the audit reports with unmodified opinion. The meeting of Board of Directors of the Company commenced at 03:00 P.M and concluded at 05.35 P.M. | |
| View all announcements for Oxygenta Pharmaceutical Ltd | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback